Sun Pharma arm picks up 14.6% stake in US company for $13 million
"...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment," Sun Pharmaceutical Industries said in a BSE filing.
Sun Pharma today said its subsidiary has invested $ 13 million (about Rs 88 crore) in the US-based scPharmaceuticals Inc.
"...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment," Sun Pharmaceutical Industries said in a BSE filing.
It further said: "Consideration for Series B preferred stock acquired is $ 13 million."
ScPharmaceuticals Inc is a United States-based pharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
The stock of Sun Pharma was trading 2.59% higher at Rs 625 on BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
12:37 pm
Sun Pharma announces agreement to acquire 60% of Vivaldis Health And Foods 
Traders' Diary: Buy, sell or hold strategy on TCS, Hero MotoCorp, Power Grid, Sun Pharma, NBCC and 15 other stocks today
Top Gainers & Losers: HDFC Life, Sun Pharma rise most among blue-chip stocks; BPCL drops
